Início
Grupos
Páginas
Ver mais
Grupos Páginas Eventos Blogs Offers Jobs Courses Fóruns Filmes Jogos
Entrar Cadastrar
Day Mode
Antisense Oligonucleotide for Cardiometabolic Disorders Market Advances with Expanding Precision Medicine Research and Innovative RNA-Based Therapeutic Development
According to the latest report published by Data Bridge Market Research, the Antisense Oligonucleotide for Cardiometabolic Disorders Market The global antisense oligonucleotide for cardiometabolic disorders market size was valued at USD 310.32 million in 2024 and is expected to reach USD 1,135.19 million by 2032, at a CAGR of 17.60% during the forecast period With the use of...
0 Comentários ·0 Compartilhamentos ·64 Visualizações ·0 Anterior
Faça o login para curtir, compartilhar e comentar!
Atualizar para Plus
Escolha o plano que é melhor para você
Atualizar